Channel Therapeutics Corp. Files 2024 10-K
Ticker: PTHS · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1919246
| Field | Detail |
|---|---|
| Company | Channel Therapeutics Corp (PTHS) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotech
TL;DR
Channel Therapeutics filed its 2024 10-K. All systems go.
AI Summary
Channel Therapeutics Corp. filed its 2024 10-K on March 27, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, formerly Chromocell Therapeutics Corp., is incorporated in Nevada and operates in the biological products sector. Its principal business address is in North Brunswick, NJ.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Channel Therapeutics Corp.'s financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific risk factors or financial performance details that would indicate a high-risk level.
Key Numbers
- 7955338 — Total Assets (Reported for fiscal year 2024)
- 513443 — Total Liabilities (Reported for fiscal year 2024)
- 7955338 — Total Equity (Reported for fiscal year 2024)
Key Players & Entities
- Channel Therapeutics Corp. (company) — Filer of the 10-K
- Chromocell Therapeutics Corp. (company) — Former name of Channel Therapeutics Corp.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-27 (date) — Filing date
- North Brunswick, NJ (location) — Business and mailing address
FAQ
What is the primary business of Channel Therapeutics Corp.?
Channel Therapeutics Corp. operates in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, SIC code 2836.
When did Channel Therapeutics Corp. change its name from Chromocell Therapeutics Corp.?
The company changed its name from Chromocell Therapeutics Corp. on March 23, 2022.
What is the fiscal year end for Channel Therapeutics Corp.?
The fiscal year end for Channel Therapeutics Corp. is December 31.
What is the filing date of this 10-K report?
This 10-K report was filed on March 27, 2025.
Where is Channel Therapeutics Corp. located?
Channel Therapeutics Corp.'s business and mailing address is 685 US Highway One, North Brunswick, NJ 08902.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Channel Therapeutics Corp (PTHS).